Literature DB >> 23249694

Branched-chain amino acids alter neurobehavioral function in rats.

Anna Coppola1, Brett R Wenner, Olga Ilkayeva, Robert D Stevens, Mauro Maggioni, Theodore A Slotkin, Edward D Levin, Christopher B Newgard.   

Abstract

Recently, we have described a strong association of branched-chain amino acids (BCAA) and aromatic amino acids (AAA) with obesity and insulin resistance. In the current study, we have investigated the potential impact of BCAA on behavioral functions. We demonstrate that supplementation of either a high-sucrose or a high-fat diet with BCAA induces anxiety-like behavior in rats compared with control groups fed on unsupplemented diets. These behavioral changes are associated with a significant decrease in the concentration of tryptophan (Trp) in brain tissues and a consequent decrease in serotonin but no difference in indices of serotonin synaptic function. The anxiety-like behaviors and decreased levels of Trp in the brain of BCAA-fed rats were reversed by supplementation of Trp in the drinking water but not by administration of fluoxetine, a selective serotonin reuptake inhibitor, suggesting that the behavioral changes are independent of the serotonergic pathway of Trp metabolism. Instead, BCAA supplementation lowers the brain levels of another Trp-derived metabolite, kynurenic acid, and these levels are normalized by Trp supplementation. We conclude that supplementation of high-energy diets with BCAA causes neurobehavioral impairment. Since BCAA are elevated spontaneously in human obesity, our studies suggest a potential mechanism for explaining the strong association of obesity and mood disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23249694      PMCID: PMC3566503          DOI: 10.1152/ajpendo.00373.2012

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  81 in total

Review 1.  Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications.

Authors:  Marion J Franz; John P Bantle; Christine A Beebe; John D Brunzell; Jean-Louis Chiasson; Abhimanyu Garg; Lea Ann Holzmeister; Byron Hoogwerf; Elizabeth Mayer-Davis; Arshag D Mooradian; Jonathan Q Purnell; Madelyn Wheeler
Journal:  Diabetes Care       Date:  2002-01       Impact factor: 19.112

Review 2.  Role of precursor availability in control of monoamine biosynthesis in brain.

Authors:  J D Fernstrom
Journal:  Physiol Rev       Date:  1983-04       Impact factor: 37.312

3.  Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: focus on individual differences.

Authors:  Anthony Laugeray; Jean-Marie Launay; Jacques Callebert; Alexandre Surget; Catherine Belzung; Pascal R Barone
Journal:  Pharmacol Biochem Behav       Date:  2010-12-16       Impact factor: 3.533

Review 4.  Obesity-depression associations in the population.

Authors:  Myles S Faith; Patty E Matz; Marie A Jorge
Journal:  J Psychosom Res       Date:  2002-10       Impact factor: 3.006

5.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

6.  Effects of myocardial infarction and captopril therapy on anxiety-related behaviors in the rat.

Authors:  J Prickaerts; W Raaijmakers; A Blokland
Journal:  Physiol Behav       Date:  1996-07

7.  Non-competitive antagonism of N-methyl-d-aspartate by displacement of an endogenous glycine-like substance.

Authors:  E J Fletcher; J D Millar; S Zeman; D Lodge
Journal:  Eur J Neurosci       Date:  1989       Impact factor: 3.386

Review 8.  Neutral amino acid transport at the human blood-brain barrier.

Authors:  W M Pardridge; T B Choi
Journal:  Fed Proc       Date:  1986-06

Review 9.  The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.

Authors:  Eniko Vamos; Arpad Pardutz; Peter Klivenyi; Jozsef Toldi; Laszlo Vecsei
Journal:  J Neurol Sci       Date:  2009-03-05       Impact factor: 3.181

Review 10.  L-kynurenine: its synthesis and possible regulatory function in brain.

Authors:  E M Gál; A D Sherman
Journal:  Neurochem Res       Date:  1980-03       Impact factor: 3.996

View more
  24 in total

Review 1.  Branched-chain amino acids in metabolic signalling and insulin resistance.

Authors:  Christopher J Lynch; Sean H Adams
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

2.  Standardization of formulations for the acute amino acid depletion and loading tests.

Authors:  Abdulla A-B Badawy; Donald M Dougherty
Journal:  J Psychopharmacol       Date:  2015-01-13       Impact factor: 4.153

3.  Branched-chain and aromatic amino acids in relation to behavioral problems among young Inuit from Nunavik, Canada: a cohort study.

Authors:  Audray St-Jean; Salma Meziou; Cynthia Roy; Pierre Ayotte; Gina Muckle; Michel Lucas
Journal:  Pediatr Res       Date:  2017-06-07       Impact factor: 3.756

4.  HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.

Authors:  Todd Bradley; Guang Yang; Olga Ilkayeva; T Matt Holl; Ruijun Zhang; Jinsong Zhang; Sampa Santra; Christopher B Fox; Steve G Reed; Robert Parks; Cindy M Bowman; Hilary Bouton-Verville; Laura L Sutherland; Richard M Scearce; Nathan Vandergrift; Thomas B Kepler; M Anthony Moody; Hua-Xin Liao; S Munir Alam; Roger McLendon; Jeffrey I Everitt; Christopher B Newgard; Laurent Verkoczy; Garnett Kelsoe; Barton F Haynes
Journal:  J Immunol       Date:  2016-11-14       Impact factor: 5.422

5.  Maternal Obesity/Diabetes, Plasma Branched-Chain Amino Acids, and Autism Spectrum Disorder Risk in Urban Low-Income Children: Evidence of Sex Difference.

Authors:  Anita A Panjwani; Yuelong Ji; Jed W Fahey; Amanda Palmer; Guoying Wang; Xiumei Hong; Barry Zuckerman; Xiaobin Wang
Journal:  Autism Res       Date:  2019-08-09       Impact factor: 5.216

6.  Metformin Promotes Anxiolytic and Antidepressant-Like Responses in Insulin-Resistant Mice by Decreasing Circulating Branched-Chain Amino Acids.

Authors:  Juliane Zemdegs; Hugo Martin; Hiranya Pintana; Sebastien Bullich; Stella Manta; Marie A Marqués; Cédric Moro; Sophie Layé; Fabien Ducrocq; Nipon Chattipakorn; Siriporn C Chattipakorn; Claire Rampon; Luc Pénicaud; Xavier Fioramonti; Bruno P Guiard
Journal:  J Neurosci       Date:  2019-06-03       Impact factor: 6.167

7.  Metabolomics analysis reveals insights into biochemical mechanisms of mental stress-induced left ventricular dysfunction.

Authors:  Stephen H Boyle; Wayne R Matson; Eric J Velazquez; Zainab Samad; Redford B Williams; Swati Sharma; Beena Thomas; Jennifer L Wilson; Christopher O'Connor; Wei Jiang
Journal:  Metabolomics       Date:  2015-06-01       Impact factor: 4.290

8.  NMR plasma metabolomics study of patients overcoming acute myocardial infarction: in the first 12 h after onset of chest pain with statistical discrimination towards metabolomic biomarkers.

Authors:  M Petras; D Kalenska; M Samos; T Bolek; M Sarlinova; P Racay; E Halasova; O Strbak; J Stasko; L Musak; M Skorvanova; E Baranovicova
Journal:  Physiol Res       Date:  2020-09-09       Impact factor: 1.881

9.  Valproate disturbs the balance between branched and aromatic amino acids in rats.

Authors:  Piotr Maciejak; Janusz Szyndler; Karolina Kołosowska; Danuta Turzyńska; Alicja Sobolewska; Jerzy Walkowiak; Adam Płaźnik
Journal:  Neurotox Res       Date:  2013-11-19       Impact factor: 3.911

Review 10.  Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions.

Authors:  Marc-Emmanuel Dumas; Laetitia Davidovic
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.